Clinical Trial Update: Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects and safety of ZGN-1061 in overweight/obese individuals with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ZGN-1061 (ZGN-1061)

Snippet

Sponsor: Zafgen, Inc. | Conditions: Type 2 Diabetes Mellitus, Overweight and Obesity | Phase 2 | Status: COMPLETED